|
Market Closed -
OTC Markets
09:31:54 2026-05-27 EDT
|
5-day change | 1st Jan Change | ||
| 10.00 USD | -16.67% |
|
-.--% | -16.67% |
Company Valuation: American Oncology Network, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Market Cap 1 | - | - | 56.35 | 137.1 |
| Change | - | - | - | 143.33% |
| Enterprise Value (EV) | - | - | 125.3 | 215.2 |
| Change | - | - | - | 71.77% |
| P/E | - | - | -4.32x | -5.7x |
| PBR | - | - | -0.35x | -3.31x |
| PEG | - | - | - | 0.2x |
| Capitalization / Revenue | - | - | 0.04x | 0.08x |
| EV / Revenue | - | - | 0x | 0x |
| EV / EBITDA | - | - | -0x | -0x |
| EV / EBIT | - | - | -0x | -0x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | - | - | -1.365 | -0.8874 |
| Distribution rate | - | - | - | - |
| Net sales 1 | 943.7 | 1,150 | 1,279 | 1,759 |
| EBITDA 1 | 6.99 | 12.28 | -4.668 | -5.575 |
| EBIT 1 | 0.911 | 5.566 | -13.12 | -16.09 |
| Net income 1 | -0.105 | 2.589 | -5.542 | -3.973 |
| Net Debt | 36.34 | 91.97 | 68.94 | 78.1 |
| Reference price 2 | 9.75 | 10.04 | 5.90 | 5.06 |
| Nbr of stocks (in thousands) | - | - | 9,550 | 27,096 |
| Announcement Date | 1/6/23 | 4/28/23 | 3/28/24 | 3/27/25 |
1USD in Million2USD
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 412M | ||
| 13.99x | 0.42x | 8.73x | 2.8% | 121B | ||
| 13.89x | 1.77x | 8.82x | 0.76% | 89.14B | ||
| 23.23x | 2.59x | 13.13x | 1.4% | 26.05B | ||
| 31.48x | 5.68x | 23.32x | 2.2% | 21.29B | ||
| 8.11x | 1.44x | 6.57x | -.--% | 21.5B | ||
| 15.28x | 1.46x | 7.45x | 4.46% | 14.5B | ||
| 14.15x | 1.01x | 5.67x | 3.48% | 12.53B | ||
| 12.29x | 1.57x | 7.62x | 0.93% | 11.43B | ||
| 51.2x | 8.58x | 32.35x | 0.2% | 10.29B | ||
| Average | 20.40x | 2.72x | 12.63x | 1.8% | 32.86B | |
| Weighted average by Cap. | 16.61x | 1.73x | 10.44x | 1.86% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- AONC Stock
- Valuation American Oncology Network, Inc.
Select your edition
All financial news and data tailored to specific country editions
















